We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Smoking choice

9 October 2018 By Robert Cyran

An ill-timed expansion left the Irish firm struggling with a tough market for generic drugs. Now it has hired a new chief who formerly ran cigarette companies, breaking a pharma-sector taboo. That’s an emphatic statement that its future lies in consumer goods.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)